Download Sample
Add to CartGlobal Coronary Artery Bypass Graft (CABG) Market Growth, Share, Size, Trends and Forecast (2025 - 2031)
By Product Type;
On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG, and Conventional CABG.By Device;
Tissue Stabilizers, Heart Positioners, Refractors, Cannulas, Cardiopulmonary Bypass Machines, Endoscopic Vessel Harvesting Systems, and Others.By Technique;
Conventional Vessel Harvesting and Endoscopic Vessel Harvesting.By End-user;
Hospitals, Cardiology Clinics, and Research & Academic Institutions.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2021 - 2031).Introduction
Global Coronary Artery Bypass Graft (CABG) Market (USD Million), 2021 - 2031
In the year 2024, the Global Coronary Artery Bypass Graft (CABG) Market was valued at USD 1,433.12 million. The size of this market is expected to increase to USD 1,924.31 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 4.3%.
Coronary artery bypass graft is a surgical procedure conducted for the treatment of heart diseases. The procedure increases blood flow and oxygen supply to the heart by diverting blood around clogged parts of the major arteries. Coronary artery bypass surgery is performed to create a new path for blood flow to the heart. In this surgery, a healthy blood vessel from another body part is used to redirect blood around the blocked artery. Adequate blood flow, lower risk of stroke, less possibility of respiratory diseases, and reduced chest pain and shortness of breath are some of the prominent advantages of the coronary artery bypass graft.
Single or multiple grafts are used in coronary surgeries depending on the number of blockages and severity of blood clotting in the arteries. These grafts are extensively employed during minimally invasive surgeries, as these surgeries entail fewer incisions and require less time to operate.
One of the most prevalent forms of cardiovascular disease, coronary artery disease (CAD), is brought on by the accumulation of plaque in the arteries that carry blood to the heart. Although coronary Artery Bypass Graft (CABG) surgeries are one of the most efficient treatments for CAD, prevalence of CAD is expected to rise. Furthermore, as the risk of getting CAD and other cardiovascular illnesses rises with age, the market expansion is anticipated to be aided by the expanding elderly population.
Revenue growth of the market is expected to be driven by rising demand for minimally invasive surgical treatments. Less pain, shorter hospital stays, and quicker recovery times for patients are all benefits of minimally invasive CABG operations, which are less invasive than conventional open-heart surgery and include fewer incisions. As a result, both patients and healthcare professionals are using these procedures more frequently.
Moreover, improvements in surgical methods and equipment are driving revenue growth of the market. For instance, the development of robotic-assisted CABG procedures is expected to transform the industry since it can improve patient outcomes and offer greater precision and control during operation. However, high cost of CABG operations, restrictive payment rules, and the availability of alternative therapy alternatives including Percutaneous Coronary Intervention (PCI) are major factors, which could restrain revenue growth of the market.
Global Coronary Artery Bypass Graft (CABG) Market Recent Developments
-
In September 2022, Edwards Lifesciences Corporation, a leading medical technology company, launched SAPIEN 3 ULTRA RESILIA VALVE. This system incorporates Edward’s breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
-
In August 2022, Grand Pharmaceutical Group of China committed to invest € 15 Mn in Xeltis, a renowned medical device firm with its clinical-stage headquarters in the Netherlands. Grand Pharmaceutical has created a polymer-based restorative device for cardiovascular treatment. The restorative device comprises heart valves and small-diameter blood vessels for coronary artery bypass graft surgery and hemodialysis vascular access.
Segment Analysis
The Global Coronary Artery Bypass Graft (CABG) market is segmented by product type into On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG, and Conventional CABG. On-pump CABG procedures involve the use of a heart-lung machine to circulate blood during surgery, while Off-pump CABG procedures are performed without the need for cardiopulmonary bypass. Minimally Invasive Direct CABG techniques aim to reduce surgical trauma and recovery time by accessing the heart through smaller incisions. Conventional CABG remains a widely used approach involving sternotomy and full cardiopulmonary bypass. By device, the market is segmented into Tissue Stabilizers, Heart Positioners, Refractors, Cannulas, Cardiopulmonary Bypass Machines, Endoscopic Vessel Harvesting Systems, and Others. These devices play crucial roles in ensuring surgical precision, maintaining heart stability, and facilitating optimal grafting. The market is further segmented by technique into Conventional Vessel Harvesting and Endoscopic Vessel Harvesting, reflecting the different approaches to obtaining graft vessels. Conventional harvesting involves open surgical dissection, while endoscopic harvesting utilizes minimally invasive techniques for vessel retrieval. Additionally, the market is segmented by end-user into Hospitals, Cardiology Clinics, and Research & Academic Institutions. Hospitals account for the largest share due to the high volume of CABG procedures performed in surgical settings, while Cardiology Clinics and Research & Academic Institutions contribute to market growth through specialized care and innovative research initiatives. With advancements in surgical techniques, device innovation, and increasing prevalence of coronary artery disease, the CABG market is poised for substantial growth, driven by the demand for effective treatment options and improved patient outcomes.
Global Coronary Artery Bypass Graft (CABG) Segment Analysis
In this report, the Global Coronary Artery Bypass Graft (CABG) Market has been segmented by Product Type, Device, Technique, End-User, and Geography.
Global Coronary Artery Bypass Graft (CABG) Market, Segmentation By Product Type
The Global Coronary Artery Bypass Graft (CABG) Market has been segmented by Product Type into On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG, and Conventional CABG.
On-pump CABG, Off-pump CABG, Minimally Invasive Direct CABG, and Conventional CABG. On-pump CABG involves the use of a heart-lung machine to temporarily take over the function of the heart and lungs during surgery, allowing the surgeon to perform the procedure on a still heart. Off-pump CABG, also known as beating-heart surgery, is performed without the use of a heart-lung machine, allowing the surgeon to operate on the heart while it is still beating. Minimally Invasive Direct CABG utilizes smaller incisions and specialized instruments to access the heart, reducing trauma to surrounding tissues and speeding up recovery time. Conventional CABG, also known as open-heart surgery, involves a traditional approach with a large incision through the breastbone to access the heart. Each type of CABG procedure offers distinct advantages and disadvantages, and the choice of technique depends on factors such as the patient's overall health, the complexity of the coronary artery disease, and the surgeon's preference. As advancements in technology and surgical techniques continue to evolve, the landscape of CABG procedures is expected to undergo further refinement, offering patients a wider range of treatment options tailored to their specific needs and preferences.
Global Coronary Artery Bypass Graft (CABG) Market, Segmentation By Device
The Global Coronary Artery Bypass Graft (CABG) Market has been segmented by Device into Tissue Stabilizers, Heart Positioners, Refractors, Cannulas, Cardiopulmonary Bypass Machines, Endoscopic Vessel Harvesting Systems, and Others.
Tissue stabilizers play a crucial role in ensuring a stable surgical field during CABG procedures, facilitating precise and controlled movement for surgeons. Heart positioners are instrumental in optimizing the positioning of the heart during surgery, enhancing visibility and access to coronary arteries. Refractors aid in maintaining clear visibility by gently retracting tissues without causing damage or obstruction. Cannulas serve as conduits for blood flow redirection during cardiopulmonary bypass procedures, ensuring adequate oxygenation and circulation. Cardiopulmonary bypass machines are indispensable devices that temporarily take over the heart's pumping function and oxygenation of blood during CABG surgery, allowing surgeons to operate on a motionless heart. Endoscopic vessel harvesting systems enable minimally invasive harvesting of vessels for grafting, reducing surgical trauma and recovery time for patients. Other devices encompass a range of instruments and tools utilized in CABG procedures, including anastomosis devices, hemostatic agents, and suction devices, among others. Each device category plays a distinct yet complementary role in ensuring the success and safety of CABG surgeries, reflecting the multifaceted nature of modern cardiac surgery techniques. This segmentation reflects the diverse array of devices utilized in CABG procedures, each serving a specific function to optimize surgical outcomes and patient safety. Tissue stabilizers provide stability and precision during vessel manipulation, while heart positioners enhance visibility and access to coronary arteries. Refractors aid in maintaining a clear surgical field, and cannulas facilitate controlled blood flow redirection during cardiopulmonary bypass. Cardiopulmonary bypass machines are pivotal in temporarily assuming heart function, allowing surgeons to operate on a motionless heart. Endoscopic vessel harvesting systems enable minimally invasive vessel procurement, reducing patient trauma and recovery time. Other devices encompass various instruments and tools essential for CABG procedures, highlighting the comprehensive nature of modern cardiac surgical techniques.
Global Coronary Artery Bypass Graft (CABG) Market, Segmentation By Technique
The Global Coronary Artery Bypass Graft (CABG) Market has been segmented by Technique into Conventional Vessel Harvesting and Endoscopic Vessel Harvesting.
Conventional Vessel Harvesting involves the traditional open surgery technique, where a long incision is made in the chest to access the blood vessels, typically the saphenous vein or the radial artery, for grafting. This technique has been widely used for many years and is known for its effectiveness in providing sufficient grafts for bypass surgery. However, it is associated with longer recovery times, increased risk of complications such as infection and wound healing issues, and greater postoperative pain for patients. On the other hand, Endoscopic Vessel Harvesting utilizes minimally invasive techniques, employing small incisions and specialized tools equipped with cameras to visualize and harvest the blood vessels. This technique offers several advantages over conventional harvesting, including reduced trauma to the patient, shorter hospital stays, faster recovery times, and improved cosmetic outcomes due to smaller incisions. Endoscopic Vessel Harvesting has gained popularity in recent years due to its ability to provide high-quality grafts while minimizing patient discomfort and accelerating the overall postoperative recovery process. Additionally, it has been associated with lower rates of wound complications and infections compared to conventional harvesting techniques. As a result, Endoscopic Vessel Harvesting is increasingly being adopted by cardiac surgeons and healthcare facilities worldwide as the preferred approach for coronary artery bypass surgery. However, it is important to note that both conventional and endoscopic harvesting techniques have their respective indications and limitations, and the choice of technique may vary depending on factors such as patient characteristics, surgeon preference, and institutional practices. Overall, the segmentation of the CABG market by technique provides valuable insights into the evolving landscape of coronary artery bypass surgery and underscores the importance of adopting innovative approaches to enhance patient outcomes and improve the overall quality of care in cardiovascular medicine.
Global Coronary Artery Bypass Graft (CABG) Market, Segmentation By End-user
The Global Coronary Artery Bypass Graft (CABG) Market has been segmented by End-user into Hospitals, Cardiology Clinics, and Research & Academic Institutions.
Hospitals stand as the primary end-user segment in the CABG market, commanding the largest share due to their pivotal role in providing comprehensive healthcare services, including surgical procedures like CABG. Hospitals are equipped with specialized facilities, advanced infrastructure, and skilled medical professionals, making them the preferred choice for patients requiring CABG surgeries. Cardiology Clinics represent another significant end-user segment in the CABG market, particularly for outpatient services and follow-up care post-surgery. These clinics specialize in the diagnosis, treatment, and management of cardiovascular diseases, offering a range of services, including diagnostic tests, consultations, and preventive care, to patients with coronary artery disease (CAD) and related conditions. Research & Academic Institutions constitute the third segment in the CABG market, playing a crucial role in advancing medical knowledge, developing innovative treatments, and training healthcare professionals. These institutions engage in clinical research, medical trials, and academic programs focused on cardiovascular diseases, including CABG procedures, contributing to advancements in surgical techniques, treatment outcomes, and patient care practices. Additionally, research institutions collaborate with hospitals and cardiology clinics to conduct studies, share expertise, and disseminate findings, thereby shaping the future landscape of CABG treatment modalities and healthcare delivery.
Global Coronary Artery Bypass Graft (CABG) Market, Segmentation by Geography
In this report, the Global Coronary Artery Bypass Graft (CABG) Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Coronary Artery Bypass Graft (CABG) Market Share (%), by Geographical Region, 2024
North American market emerged as the leader in revenue generation for Coronary Artery Bypass Graft (CABG) procedures. This dominance can be attributed to several key factors. Firstly, the aging population in the region has led to an increased incidence of cardiovascular diseases, consequently driving the demand for CABG surgeries. Additionally, the region has witnessed significant advancements in medical technology and techniques, particularly in the field of minimally invasive procedures. The growing acceptance of these less invasive methods among patients has further fueled the growth of the CABG market in North America.
Meanwhile, the Asia Pacific region is projected to experience the highest compound annual growth rate (CAGR) in revenue during the forecast period. This rapid growth can be attributed to several factors, including the rising disposable income levels and the increasing demand for improved healthcare services in countries like China and India. Moreover, the prevalence of cardiovascular diseases is on the rise in these developing nations, contributing to the growing need for CABG surgeries. Additionally, the availability of affordable CABG treatments and the expansion of healthcare infrastructure across the region are further propelling market growth.
In Europe, the CABG market is expected to witness moderate revenue growth over the forecast period. This can be attributed to the region's high prevalence of cardiovascular disorders and the adoption of innovative medical technologies. European countries have been increasingly emphasizing patient safety and advocating for individualized healthcare services, which is expected to drive the demand for CABG procedures in the region. As a result, advancements in medical technology and the implementation of personalized healthcare approaches are likely to contribute to the revenue growth of the CABG market in Europe.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Coronary Artery Bypass Graft (CABG) Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing Prevalence of Coronary Artery Disease (CAD)
- Advancements in Surgical Techniques and Technologies
-
Increasing Healthcare Expenditure- As healthcare expenditure continues to rise, both in developed and developing countries, there is a notable expansion in healthcare infrastructure, medical technology, and access to specialized cardiac care services. This increased investment in healthcare systems translates into improved access to CABG procedures for patients suffering from coronary artery disease (CAD), a condition characterized by the narrowing or blockage of coronary arteries, often requiring surgical intervention to restore blood flow to the heart.
With higher healthcare expenditure, hospitals can invest in state-of-the-art cardiac surgery facilities, including advanced operating rooms, cardiac catheterization laboratories, and intensive care units, equipped with the latest medical devices and technologies necessary for performing CABG surgeries safely and effectively. Additionally, increased healthcare spending allows healthcare providers to recruit and retain skilled cardiac surgeons, cardiac anesthesiologists, and cardiac nursing staff, ensuring the availability of a qualified workforce to perform CABG procedures and provide comprehensive perioperative care to patients. Moreover, higher healthcare expenditure enables hospitals to offer comprehensive cardiac rehabilitation programs and post-operative follow-up care, addressing the holistic needs of patients undergoing CABG surgery and promoting better long-term outcomes.
Restraints
- High Cost of Procedure
- Technological Limitations
-
Availability of Alternative Treatments- As medical science progresses, alternative treatment options for coronary artery disease (CAD) have emerged, offering patients choices beyond traditional CABG surgery. One notable alternative is percutaneous coronary intervention (PCI), commonly known as angioplasty or stenting. PCI involves the insertion of a catheter with a balloon at its tip into the blocked coronary artery, followed by inflation to widen the artery and placement of a stent to keep it open. This minimally invasive procedure has gained popularity due to its shorter recovery times, reduced risk of complications, and avoidance of open-heart surgery. Additionally, advancements in medical therapy, including the use of medications such as statins, antiplatelet agents, and beta-blockers, have proven effective in managing CAD symptoms and reducing the need for invasive procedures like CABG.
Furthermore, lifestyle modifications such as diet and exercise interventions, smoking cessation programs, and stress management techniques are increasingly emphasized as integral components of CAD management, further diminishing the reliance on surgical interventions like CABG. As a result, patients and healthcare providers may opt for these alternative treatments over CABG surgery, particularly for less severe cases of CAD or in individuals who are deemed high-risk candidates for surgery. This trend towards alternative treatments poses a challenge to the CABG market, potentially impacting procedure volumes and revenue streams for hospitals, surgical centers, and medical device manufacturers specializing in CABG equipment. Moreover, the availability of alternative treatments underscores the importance of patient-centered care and shared decision-making between healthcare providers and patients in determining the most appropriate treatment approach based on individual clinical circumstances, preferences, and goals. Therefore, stakeholders in the CABG market must adapt to evolving patient needs and preferences, invest in research and development to enhance procedural outcomes and patient satisfaction, and collaborate with healthcare partners to ensure comprehensive and personalized care for CAD patients.
Opportunities
- Patient Education and Awareness
-
Focus on Outcomes-Based Healthcare- In an outcomes-based healthcare model, the emphasis is placed on achieving optimal patient outcomes, such as improved quality of life, reduced hospital readmissions, and extended longevity, rather than solely focusing on the volume of procedures performed. This shift in healthcare delivery incentivizes healthcare providers to adopt evidence-based practices, implement standardized protocols, and prioritize interventions that have demonstrated effectiveness in improving patient outcomes. For CABG surgery, outcomes-based healthcare encourages the adoption of best practices in surgical techniques, perioperative care, and postoperative management to minimize complications, enhance recovery, and optimize long-term survival rates for patients with coronary artery disease (CAD).
Healthcare providers are incentivized to track and report key performance indicators related to CABG outcomes, such as mortality rates, graft patency, and functional status, to demonstrate the value and effectiveness of CABG surgery in improving patient health and well-being. Additionally, outcomes-based healthcare fosters collaboration among multidisciplinary healthcare teams, including surgeons, cardiologists, nurses, and rehabilitation specialists, to coordinate care across the continuum and ensure seamless transitions from hospital to home. By aligning incentives with patient outcomes, outcomes-based healthcare promotes a patient-centered approach to CABG surgery, where the focus is on delivering high-quality, cost-effective care that maximizes the benefits for patients while minimizing unnecessary interventions and healthcare costs. Overall, the adoption of outcomes-based healthcare in the CABG market presents opportunities for healthcare providers to enhance the value and efficiency of cardiovascular care delivery, drive continuous quality improvement initiatives, and ultimately improve the health outcomes and quality of life for patients undergoing CABG surgery.
Competitive Landscape Analysis
Key players in Global Coronary Artery Bypass Graft (CABG) Market include:
- Abbott Laboratories
- Boston Scientific Corporation
- Edwards Lifesciences Corporation
- HeartWare International, Inc.
- MAQUET Holding B.V. & Co. KG
- Medtronic plc
- Sorin Group
- St. Jude Medical, Inc.
- Swissray Global Healthcare Holding, Ltd.
- Teleflex Incorporated
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Device
- Market Snapshot, By Technique
- Market Snapshot, By End-user
- Market Snapshot, By Region
- Global Coronary Artery Bypass Graft (CABG) Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
-
Increasing Prevalence of Coronary Artery Disease (CAD)
-
Advancements in Surgical Techniques and Technologies
-
Increasing Healthcare Expenditure
-
- Restraints
-
High Cost of Procedure
-
Technological Limitations
-
Availability of Alternative Treatments
-
- Opportunities
-
Patient Education and Awareness
-
Focus on Outcomes-Based Healthcare
-
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Coronary Artery Bypass Graft (CABG) Market, By Product Type, 2021 - 2031 (USD Million)
- On-pump CABG
- Off-pump CABG
- Minimally Invasive Direct CABG
- Conventional CABG
- Global Coronary Artery Bypass Graft (CABG) Market, By Device, 2021 - 2031 (USD Million)
- Tissue Stabilizers
- Heart Positioners
- Refractors
- Cannulas
- Cardiopulmonary Bypass Machines
- Endoscopic Vessel Harvesting Systems
- Others
- Global Coronary Artery Bypass Graft (CABG) Market, By Technique, 2021 - 2031 (USD Million)
- Conventional Vessel Harvesting
- Endoscopic Vessel Harvesting
-
Global Coronary Artery Bypass Graft (CABG) Market, By End-User, 2021 - 2031 (USD Million)
-
Hospitals
-
Cardiology Clinics
-
Research & Academic Institutions
-
- Global Coronary Artery Bypass Graft (CABG) Market, By Geography, 2021 - 2031 (USD Million)
-
North America
-
United States
-
Canada
-
-
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Nordic
-
Benelux
-
Rest of Europe
-
-
Asia Pacific
-
Japan
-
China
-
India
-
Australia & New Zealand
-
South Korea
-
ASEAN (Association of South East Asian Countries)
-
Rest of Asia Pacific
-
-
Middle East & Africa
-
GCC
-
Israel
-
South Africa
-
Rest of Middle East & Africa
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
Rest of Latin America
-
-
- Global Coronary Artery Bypass Graft (CABG) Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
-
Abbott Laboratories
-
Boston Scientific Corporation
-
Edwards Lifesciences Corporation
-
HeartWare International, Inc.
-
MAQUET Holding B.V. & Co. KG
-
Medtronic plc
-
Sorin Group
-
St. Jude Medical, Inc.
-
Swissray Global Healthcare Holding, Ltd.
-
Teleflex Incorporated
-
- Company Profiles
- Analyst Views
- Future Outlook of the Market